• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • MS Advocate Challenge
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact Development
Home - OMRF News - Archives for pharma

pharma

Can big pharma save us all?

January 3, 2021

When Covid-19 arrived on our shores, we didn’t look to the government for rescue. We pinned our hopes on the pharmaceutical industry.

Filed Under: COVID-19 News, On Your Health Tagged With: adam, big pharma, cohen, corona, coronavirus, covid, eli lily, moderna, news, newsok, OKC, Oklahoma Medical Research Foundation, OMRF, Pfizer, pharma, Prescott, stephen, steve, vaccination, vaccine

OMRF discovers compound that could fight deadly cancer

January 21, 2019

Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.

Filed Under: News Tagged With: biomedical, brain, brain cancer, cancer, compound, cure, developed, drug, eltd1, glioblastoma, john mccain, medicine, news, newsok, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, pharma, Rheal, rheal towner, scientist-news, ted kennedy, Towner, treat, treatment

OMRF researcher tests new approach for treating deadly blood infection

July 18, 2017

Lupu’s findings were published in the Proceedings of the National Academy of Sciences.

Filed Under: News Tagged With: bacteria, biomedical, blood, Coggeshall, complement activation system, condition, damage, deadly, defense, drug, er, failure, Florea, Florea Lupu, hospital, immune system, journal, K., lab, Lupu, NIAID, NIGMS, NIH, OKC, Oklahoma, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, organ, pathogens, pharma, PNAS, ra pharma, research, science, scientist-news, sepsis, therapy

Venture capital, biotech execs converge on OMRF

April 8, 2015

Networking, lab tours highlight first OMRF BioVenture Forum

Filed Under: News, Research News Tagged With: AstraZeneca, biotech, BioVenture, BioVenture Forum, Charles, charles esmon, Congressman Tom Cole, Craig Wegner, Crescendo Bioscience, diagnostics, Esmon, Gene Liau, Gov Mary Fallin, Manu Nair, Nair, OMRF BioVenture Forum 2015, Pfizer, pharma, pharmaceutical, scientist-news, technology ventures, venture capital, William Hagstrom

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace